Sulzer Looking To Double Medical Device Revenues Over Next Two Years

Sulzer says it plans to roughly double the size of its core cardiovascular/orthopedic device and materials technology businesses within two years to approximately $2 bil. and at the same time maintain a "significant focus" on biotechnology.